Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Nexalis Issues Settlement Options To Linlithgow Family Office

NX1: $0.008 +0.00% · MC: $2M

Nexalis Therapeutics has issued 15 million unlisted options to Linlithgow Family Office as settlement for funding received under its former facility. The options replace 38.4 million older options, which were cancelled when the facility was terminated; the settlement leaves no repayment obligation to the lender.

Source announcements: 2026-11-11 13:00 to 2026-11-11 13:00 Sydney time
Story updated 2026-11-11 13:01 Sydney time
SourcesNotification regarding unquoted securities - NX1
Comments